BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.01) EPS for the quarter, Zacks reports.
BioNxt Solutions Trading Down 6.3%
OTCMKTS BNXTF traded down $0.02 during mid-day trading on Friday, hitting $0.29. The company’s stock had a trading volume of 5,000 shares, compared to its average volume of 3,186. The firm has a market capitalization of $35.04 million, a price-to-earnings ratio of -7.15 and a beta of 0.69. The company’s 50 day simple moving average is $0.35 and its 200 day simple moving average is $0.42. BioNxt Solutions has a twelve month low of $0.14 and a twelve month high of $0.80.
About BioNxt Solutions
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Read More
- Five stocks we like better than BioNxt Solutions
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
